Cross-Modality Comparisons Between Radiofrequency Ablation and Stereotactic Body Radiotherapy for Treatment of Hepatocellular Carcinoma: Limitations of the National Cancer Database
Jeffrey R. Olsen(University of Colorado Denver), Salma K. Jabbour(Rutgers, The State University of New Jersey), Smith Apisarnthanarax(University of Washington), F. Huguet(Sorbonne Université), Christopher L. Hallemeier(Mayo Clinic in Arizona), James D. Murphy(University of California San Diego)
Cited by 3
Related Papers
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
|Annals of Surgery|2019|445
Adaptive Radiation Therapy (ART) Strategies and Technical Considerations: A State of the ART Review From NRG Oncology
|International Journal of Radiation Oncology*Biology*Physics|2020|314
Oesophageal cancer
|The Lancet|2024|265